CNTX – context therapeutics inc. (US:NASDAQ)
Stock Stats
News
Integral Molecular's Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors [Yahoo! Finance]
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Context Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Context Therapeutics to Participate in Upcoming Investor Conferences
Form 8-K Context Therapeutics For: Feb 27
Form SCHEDULE 13G/A Context Therapeutics Filed by: Blue Owl Capital Holdings LP
Form SCHEDULE 13G/A Context Therapeutics Filed by: GREAT POINT PARTNERS LLC
Form 4 Context Therapeutics For: Feb 13 Filed by: Minai-Azary Jennifer Lynn
Form 4 Context Therapeutics For: Feb 13 Filed by: Levit Alex C.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.